Managers shouldn't make these decisions alone
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
This secondary analysis evaluated changes in key cardiovascular risk factors over time, including glycated hemoglobin A 1c (HbA 1c ), body weight, and BP, using estimated treatment differences, as well as inflammatory and lipid markers, such as high-sensitivity C-reactive protein (hsCRP) and cholesterol parameters, using estimated treatment ratios
Rotate the injection site each time to avoid irritation
For the study, WashU Medicine researchers analyzed de-identified medical records in a database maintained by the U.S
Avoiding alcohol, which causes vasodilation and can worsen hypotension, is advisable, particularly during the adjustment period